Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

19.00

+0.41 (2.21%)

At close: Mar 9, 2026, 4:00 PM EDT

18.65

-0.35 (-1.84%)

After-hours: Mar 9, 2026, 7:59 PM EDT

Caris Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-68.09	-281.89	-341.42	-320.83
Depreciation & Amortization	22.62	48.91	49	48.25
Other Amortization	12.77	7.05	5.38	2.65
Stock-Based Compensation	70.01	18.64	15.24	22.9
Other Operating Activities	78.98	-8.85	2.82	-16.43
Change in Accounts Receivable	-29.79	-33.82	-15.08	-11.91
Change in Inventory	-20.75	5.46	-4.44	-11.1
Change in Accounts Payable	11.04	-0.23	7.17	8.91
Change in Other Net Operating Assets	6.38	-0.48	5.22	-8.16
Operating Cash Flow	83.16	-245.2	-276.1	-285.71
Capital Expenditures	-16.26	-8.44	-22.32	-42.26
Investment in Securities	-	61.38	237.09	-240.73
Investing Cash Flow	-16.26	52.93	214.77	-282.99
Long-Term Debt Issued	27.87	199.98	191.31	-
Long-Term Debt Repaid	-0.11	-0.16	-180.74	-0.96
Net Debt Issued (Repaid)	27.76	199.82	10.57	-0.96
Issuance of Common Stock	536.1	1.53	1.87	11.41
Repurchase of Common Stock	-18.66	-	-	-
Other Financing Activities	-1.44	-1.06	-2.3	-
Financing Cash Flow	664.99	200.29	10.13	10.45
Foreign Exchange Rate Adjustments	0.13	-0	0.06	0
Net Cash Flow	732.01	8.02	-51.13	-558.25
Free Cash Flow	66.9	-253.64	-298.42	-327.96
Free Cash Flow Margin	8.24%	-61.52%	-97.48%	-126.88%
Free Cash Flow Per Share	0.40	-7.15	-8.54	-9.83
Cash Interest Paid	43.52	49.02	15.78	24.24
Levered Free Cash Flow	53.5	-143.65	-178.04	-
Unlevered Free Cash Flow	76.27	-119.44	-163.66	-
Change in Working Capital	-33.13	-29.07	-7.13	-22.26

Source: S&P Capital IQ. Standard template. Financial Sources.